HARRISBURG, Pa. - Merck & Co. is paying US$58 million as part of a multistate settlement concerning advertising of the now-withdrawn painkiller, Vioxx.
The settlement announced Tuesday addresses allegations that Merck's advertising deceptively downplayed the health risks of Vioxx. New Jersey-based Merck is not admitting any wrongdoing under the settlement.
Pennsylvania Attorney General Tom Corbett says the settlement ends investigations by 29 states and the District of Columbia into Merck's advertising practices involving Vioxx.
The settlement also calls for Merck to submit all new TV commercials for its drugs to the FDA for review.
Vioxx was taken off the market in 2004 after research showed it doubled the risk of heart attacks and strokes.
©All rights reserved, news from Canadian Press
Weather: Montreal, July 25th 2008 / 24°C
/ A few clouds
/ Wind: 28 Km/h / Humidity: 65 % 
Article online since May 20th 2008, 0:00
Steven Guilbeault - Environment Column
Richard Cléroux - National Columnist
